ERIKA EUKER: Open Payments
NPI 1265925911 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 64 payments from 13 companies in 2025. Trend: 2023 $83 · 2024 $1,681 · 2025 $1,280
Food & beverage: $1,198Education: $82
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $302 |
| Amgen Inc. | 9 | $266 |
| ABBVIE INC. | 15 | $201 |
| Regeneron Healthcare Solutions, Inc. | 7 | $177 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Galderma Laboratories, L.P. | 2 | $56 |
| Incyte Corporation | 2 | $50 |
| GENZYME CORPORATION | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Organon LLC | 3 | $22 |
Products named: TREMFYA, OTEZLA, SKYRIZI, DUPIXENT, COSENTYX, LIBTAYO, NEMLUVIO, OPZELURA.
Industry payments across WA — which companies pay providers there.
